Skip to main content
HAINAN HAIYAO CO.,LTD logo

HAINAN HAIYAO CO.,LTD — Investor Relations & Filings

Ticker · 000566 ISIN · CNE0000004W8 LEI · 30030014HR68SK419386 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,731 across all filing types
Latest filing 2026-05-08 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 000566

About HAINAN HAIYAO CO.,LTD

https://www.haiyao.com.cn

Hainan Haiyao Co., Ltd. specializes in the research, development, manufacturing, and distribution of pharmaceutical products and medical devices. The company's core product portfolio encompasses cephalosporin antibiotics, gastrointestinal medications, anti-tumor drugs, and nutritional supplements. A significant aspect of its operations includes the production of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), ensuring an integrated supply chain for finished dosage forms. Beyond traditional pharmaceuticals, the company is a developer of medical equipment, notably artificial cochlear implants. Its business model emphasizes technological innovation and quality control across its diverse therapeutic categories, serving both clinical and consumer health needs through a comprehensive range of chemical drugs and biological products.

Recent filings

Filing Released Lang Actions
上海市锦天城（深圳）律师事务所关于海南海药股份有限公司2025年年度股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2025 annual shareholders' meeting of Hainan Haiyao Co., Ltd. It details the procedures for convening and holding the meeting, the qualifications of attendees, the voting procedures, and the voting results for various proposals. The document does not contain financial statements or management discussion but focuses on the legality and validity of the shareholders' meeting process and results. It is not the annual report itself, nor an announcement of the report publication, but a legal opinion related to the shareholders' meeting. This type of document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports official voting results and related procedural confirmations from the shareholders' meeting.
2026-05-08 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 Annual General Meeting (AGM) of 海南海药股份有限公司. It includes information about the meeting date, voting procedures, attendance, and the voting results on various agenda items such as the 2025 board work report, annual report approval, profit distribution plan, loan credit limits, and director remuneration. It also mentions legal witness and compliance with relevant laws. The document is not the full annual report itself but the official announcement of the voting results and resolutions from the AGM. The document length is about 3,086 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-08 Chinese
关于参加海南辖区上市公司 2025 年年报业绩说明会暨投资者网上集体接待日活动的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the company's participation in an investor meeting focused on the 2025 annual report performance explanation and investor interaction. It is a notice of an upcoming event rather than the report itself. The document is short (497 characters) and does not contain financial statements or detailed analysis. It fits the category of an Investor Presentation (IP) since it involves a presentation and discussion of financial results and company strategy with investors.
2026-05-07 Chinese
关于股东减持计划实施完成的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the completion of a shareholder's share reduction plan, detailing the number of shares reduced, the methods, dates, and compliance with relevant securities laws. It includes specific data on shareholding changes but does not contain financial statements or detailed financial analysis. The content focuses on shareholding changes by a significant shareholder and compliance with regulations. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2026-05-07 Chinese
2026年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions from the 2026 first extraordinary shareholders meeting of Hainan Haiyao Co., Ltd. It details the meeting date, voting procedures, attendance, voting results on specific proposals, and legal opinions from lawyers witnessing the meeting. It does not contain financial statements or detailed financial analysis but reports the official voting results and meeting outcomes. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2468 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the correct classification is DVA.
2026-03-13 Chinese
关于与新兴际华集团财务有限公司签署《金融服务协议》的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the signing and renewal of a financial services agreement between the company (Hainan Haiyao) and a related party (Xinxing Jihua Group Finance Co., Ltd.). It includes information about the transaction overview, related party details, pricing principles, main contents of the agreement, transaction limits, rights and obligations, breach liabilities, dispute resolution, and the impact on the company. It also mentions board and independent director approvals. The document is a formal announcement of a related party transaction and financial services agreement, not a financial report, earnings release, or management discussion. It does not contain financial statements or quarterly/yearly financial results. It is not a regulatory filing or certification letter either, but a specific announcement about a capital/financing related agreement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2026-02-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.